<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>Novartis International AG</title>
<link>http://www.novartis.com</link>
<item>
<title>Novartis Consumer Health Inc. voluntarily recalls certain over-the-counter products in the US while Novartis Group strengthens quality standards across all manufacturing sites</title>
<pubDate>2012-01-08T17:47:08 CET</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/en/2012/1575836.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis makes strong start for the year</title>
<pubDate>2011-04-19T07:00:00 CET</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/en/2011/1507510.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis appoints Naomi Kelman as new Head of the Novartis OTC division</title>
<pubDate>2011-02-17T07:00:00 CET</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/en/2011/1489895.shtml</link>
<description> 
</description>
</item>
<item>
<title>Innovation drives Novartis to double-digit growth for 2010</title>
<pubDate>2011-01-27T07:00:00 CET</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/en/2011/1482782.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis delivers excellent performance in third quarter: recently launched products generate 20%* of sales; Gilenya approved; Alcon consolidated</title>
<pubDate>2010-10-21T07:00:00 CET</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/en/2010/1453762.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis delivers strong financial performance in second quarter, underpinned by increased momentum in innovation</title>
<pubDate>2010-07-15T07:00:00 CET</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/en/2010/1431809.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis provides progress-update to achieving 77% majority ownership of Alcon</title>
<pubDate>2010-06-30T22:45:00 CET</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/en/2010/1428790.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis démarre l'année en force</title>
<pubDate>2011-04-19T07:00:00+01:00</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/fr/2011/1507511.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis nomme Naomi Kelman directrice de la division Novartis OTC</title>
<pubDate>2011-02-17T07:00:00 CET</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/fr/2011/1489897.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis: l'innovation entraîne une croissance à deux chiffres en 2010</title>
<pubDate>2011-01-27T07:00:00+01:00</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/fr/2011/1482783.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis réalise une excellente performance au troisième trimestre: les produits lancés récemment génèrent 20%* du chiffre d'affaires, homologation de Gilenya, consolidation d'Alcon</title>
<pubDate>2010-10-21T07:00:00+01:00</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/fr/2010/1453758.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis startet kraftvoll in das Jahr 2011</title>
<pubDate>2011-04-19T07:00:00+01:00</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/de/2011/1507512.shtml</link>
<description> 
</description>
</item>
<item>
<title>Novartis ernennt Naomi Kelman zur neuen Leiterin der OTC-Division von Novartis</title>
<pubDate>2011-02-17T07:00:00 CET</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/de/2011/1489896.shtml</link>
<description> 
</description>
</item>
<item>
<title>Gestützt auf eine verstärkte Innovationsdynamik erzielt Novartis im zweiten Quartal eine starke finanzielle Performance</title>
<pubDate>2010-07-15T07:00:00+01:00</pubDate>
<link>http://www.novartis.com/newsroom/media-releases/de/2010/1431807.shtml</link>
<description> 
</description>
</item>
</channel>
</rss>
